Molecule Details
| InChIKey | NVDJRUZWJVKEIQ-HXUWFJFHSA-N |
|---|---|
| Compound Name | N-(azetidin-1-ylsulfonyl)-4-[(3R)-1-benzylpiperidin-3-yl]oxy-5-cyclopropyl-2-fluorobenzamide |
| Canonical SMILES | O=C(NS(=O)(=O)N1CCC1)c1cc(C2CC2)c(O[C@@H]2CCCN(Cc3ccccc3)C2)cc1F |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.51 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
Target Activities (3)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q15858 | SCN9A | Homo sapiens | Human | PF00520 PF24609 PF06512 PF11933 | 7.7 | IC50 | ChEMBL;BindingDB |
| Q14524 | SCN5A | Homo sapiens | Human | PF00520 PF24609 PF06512 PF11933 | 7.5 | IC50 | BindingDB |
| P35498 | SCN1A | Homo sapiens | Human | PF00520 PF24609 PF06512 PF11933 | 7.4 | IC50 | BindingDB |